TLSA ▲ +8.9% - Tiziana Life Sciences Ltd
$TLSA - Tiziana Announces Positive Topline Results from Phase 2a INFORM-MS Trial of Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
02-NOV-2026 07:00 AM ET
Share this post
More filings for $TLSA
TLSA - Tiziana Life Sciences Ltd - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026TLSA ▲ +1.6% - Tiziana Life Sciences LtdNov 12, 2026TLSA ▼ -1.4% - Tiziana Life Sciences LtdNov 9, 2026TLSA ▼ -1.4% - Tiziana Life Sciences LtdNov 9, 2026TLSA ▲ +1.0% - Tiziana Life Sciences LtdOct 21, 2026TLSA ▲ +2.9% - Tiziana Life Sciences LtdOct 16, 2026
View full $TLSA filing history →💬 Comments
Loading comments…
Leave a comment
